Loading organizations...
§ Private Profile · Bank of America Tower, Fort Worth, Texas, United States
Texas Pacific Group is a company.
TPG functions as a leading global alternative asset manager, managing diverse investment portfolios across its platforms. Its distinctive approach centers on innovation-led growth, leveraging disruption and technology to incubate, launch, and scale new investment vehicles. The firm strategically expands its capabilities, evidenced by its entry into credit and real estate.
Jim Coulter and David Bonderman, former colleagues from the Bass Family Office, established TPG in 1992. Their foundational insight aimed to build an alternative investment firm prioritizing innovation, an affinity for technological disruption, and an open, collaborative culture, guiding its trajectory.
The firm serves institutional investors and capital partners within the alternative asset landscape. TPG’s vision is to shape the future of alternative asset management through scaling and diversification, fostering an inclusive culture reflecting its clientele and portfolio companies.
Key people at Texas Pacific Group.
Texas Pacific Group was founded in 1992 by James Coulter (Founder) and David Bonderman (Founder) and Kelvin L. Davis (Partner and Founder) and Jim Coulter (Co-Founder and Founding Partner) and William S. Price (Founder) and Yemi Lalude (Founder) and Kelvin Davis (Founder and Co-head) and Jeffrey A Shaw (Co-Founder and General Partner).
Texas Pacific Group was founded in 1992 by James Coulter (Founder) and David Bonderman (Founder) and Kelvin L. Davis (Partner and Founder) and Jim Coulter (Co-Founder and Founding Partner) and William S. Price (Founder) and Yemi Lalude (Founder) and Kelvin Davis (Founder and Co-head) and Jeffrey A Shaw (Co-Founder and General Partner).
Texas Pacific Group has 2 tracked investments across 2 companies. The latest tracked deal is $32.0M Series B in Entasis Therapeutics in September 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2017 | Entasis Therapeutics | $32.0M Series B | — | Dolby Family Ventures, Pivotal BioVenture Partners, SR ONE, Heather Preston, Heather Behanna |
| Aug 1, 2010 | Otonomy | $39.0M Series B | Peter Bisgaard, John Mckearn | Domain Associates, ED Mathers, Pivotal BioVenture Partners, Rivervest, Heather Preston, Avalon Ventures |
Key people at Texas Pacific Group.
TPG (formerly Texas Pacific Group) is a leading global alternative asset manager headquartered in San Francisco, managing $286 billion in assets as of September 30, 2025.[3][4] Its mission centers on a principled focus on innovation, leveraging family office roots, entrepreneurial heritage, and a West Coast base to drive innovation-led growth, disruption via technology, and collaborative culture across diversified strategies.[3][4] TPG's investment philosophy emphasizes organic growth, thematic deep dives in dynamic sectors, and a multi-platform approach combining financial engineering with hands-on operating support; key sectors span technology, healthcare, consumer/retail, financial services, real estate, and impact investing.[1][2][3] With over 600 portfolio companies historically—including high-profile deals like Continental Airlines (1993), Petco (2000), and Burger King (2002)—TPG significantly influences the startup and growth ecosystem through growth equity ($31B AUM), impact funds like The Rise Fund ($29B AUM), and large-scale private equity ($87B AUM), fostering innovation in zero-trust cybersecurity, Asian healthcare, and beyond.[1][2][3][6]
TPG was founded in 1992 by David Bonderman, Jim Coulter, and initially William S. Price III, who were former colleagues at the Bass Family Office; they started with a single San Francisco office and a pivotal $66 million investment in the distressed buyout of Continental Airlines in 1993.[1][2][4] Originally named Texas Pacific Group, the firm evolved from a private equity focus on leveraged buyouts into a diversified alternative asset manager, expanding globally with 12 offices and building significant operations in Asia and Europe during the 1990s.[1][2] Key milestones include going public via a 2022 NASDAQ IPO valuing it at $9–10 billion, acquiring Angelo Gordon in 2023 for $2.7 billion to bolster credit and real estate, and leadership transition to sole CEO Jon Winkelried in 2021.[2][4] This trajectory reflects a shift toward multi-platform strategies encompassing private equity, growth, impact, credit, real estate, and market solutions.[3]
TPG rides trends in alternative assets amid rising demand for diversified, innovation-driven strategies, particularly in tech-enabled disruption (e.g., zero-trust cybersecurity), Asian healthcare, and ESG/impact investing.[3][6] Timing aligns with post-2022 public markets access for PE, the 2023 Angelo Gordon acquisition amid credit market growth, and a shift from generalist to sector-oriented models, where TPG's specialization in dynamic sectors like technology and healthcare provides a competitive edge.[2][4][5] Market forces favoring it include private wealth inflows (via open-end funds and Wealth Solutions), secondaries/continuation vehicles, and GPs building in-house capabilities—TPG influences the ecosystem by scaling impact platforms, enabling individual access to institutional deals, and shaping PE's migration toward thematic, hands-on specialization.[3][5]
TPG is poised to expand its multi-platform dominance, potentially launching more continually offered PE products for private wealth and deepening secondaries/credit via Angelo Gordon amid maturing alternatives markets.[3][5] Trends like AI-driven tech disruption, Asia's healthcare boom, and ESG integration will shape its path, with influence evolving toward greater retail access and sector leadership in high-growth areas. As a pioneer from Texas Pacific Group roots to $286B innovator, TPG exemplifies how principled innovation sustains elite status in evolving private markets.[2][3][4]
